Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

MAMMALIAN PHENOTYPE - ANNOTATIONS

The Mouse Adult Gross Anatomy Ontology and Mammalian Phenotype Ontology are downloaded weekly from the Mouse Genome Informatics databases at Jackson Laboratories (ftp://ftp.informatics.jax.org/pub/reports/index.html). For more information about these ontologies, see the MGI Publications Page at http://www.informatics.jax.org/mgihome/other/publications.shtml.

Term:increased mammary gland tumor incidence
go back to main search page
Accession:MP:0010299 term browser browse the term
Definition:greater than the expected number of neoplasms in the mammary gland, usually in the form of a distinct mass, in a specific population in a given time period
Synonyms:exact_synonym: increased mammary gland tumour incidence;   increased susceptibility to mammary neoplasm
 alt_id: MP:0006318


show annotations for term's descendants           Sort by:
 
increased mammary gland tumor incidence term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Mcs29 Mammary carcinoma susceptibility QTL 29 IDA RGD PMID:21205740 RGD:5684388 NCBI chr 5:80,229,223...80,401,274 JBrowse link
Q Mcs30 Mammary carcinoma susceptibility QTL 30 IDA RGD PMID:24023717 RGD:7327193 NCBI chr12:1,258,139...10,257,059 JBrowse link
Q Mcs31 Mammary carcinoma susceptibility QTL 31 IDA RGD PMID:23967281 RGD:7794780 NCBI chr 9:90,024,661...119,983,851 JBrowse link
Q Mcs32 Mammary carcinoma susceptibility QTL 32 IDA RGD PMID:23967281 RGD:7794780 NCBI chr 1:122,614,824...262,664,716 JBrowse link
Q Mcs33 Mammary carcinoma susceptibility QTL 33 IDA RGD PMID:23967281 RGD:7794780 NCBI chr 5:136,640,731...173,707,219 JBrowse link
Q Mcs34 Mammary carcinoma susceptibility QTL 34 IDA RGD PMID:23967281 RGD:7794780
increased mammary adenocarcinoma incidence term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Emca1 Estrogen-induced mammary cancer QTL 1 IAGP RGD PMID:15611180 RGD:1358124 NCBI chr 5:102,945,579...154,732,228 JBrowse link
Q Emca11 Estrogen-induced mammary cancer QTL 11 IDA RGD PMID:23151807 RGD:7364727 NCBI chr 5:103,580,245...117,037,276 JBrowse link
Q Emca12 Estrogen-induced mammary cancer QTL 12 IDA RGD PMID:23151807 RGD:7364727 NCBI chr 5:129,038,716...139,099,229 JBrowse link
Q Emca13 Estrogen-induced mammary cancer QTL 13 IDA RGD PMID:23151807 RGD:7364727 NCBI chr 5:9,514,842...103,580,403 JBrowse link
Q Emca2 Estrogen-induced mammary cancer QTL 2 IAGP RGD PMID:15611180 RGD:1358124 NCBI chr18:19,031,030...68,436,105 JBrowse link
Q Emca4 Estrogen-induced mammary cancer QTL 4 susceptibility IDA estrogen induced RGD PMID:16885383 RGD:1642522 NCBI chr 7:69,399,586...111,043,530 JBrowse link
Q Emca5 Estrogen-induced mammary cancer QTL 5 susceptibility IDA estrogen induced RGD PMID:16885383 RGD:1642522 NCBI chr 3:45,406,058...177,699,992 JBrowse link
Q Emca6 Estrogen-induced mammary cancer QTL 6 susceptibility IDA estrogen induced RGD PMID:16885383 RGD:1642522 NCBI chr 4:43,414,605...155,469,929 JBrowse link
Q Emca7 Estrogen-induced mammary cancer QTL 7 IDA estrogen induced RGD PMID:16885383 RGD:1642522 NCBI chr 6:2,537,030...111,715,717 JBrowse link
Q Emca8 Estrogen-induced mammary cancer QTL 8 susceptibility IDA estrogen induced RGD PMID:16885383 RGD:1642522 NCBI chr 5:51,418,671...147,487,820 JBrowse link
Q Mamtr5 Mammary tumor resistance QTL 5 IDA RGD PMID:17230524 RGD:1599390 NCBI chr 5:18,847,913...63,847,913 JBrowse link
Q Mamtr6 Mammary tumor resistance QTL 6 IDA RGD PMID:17230524 RGD:1599390 NCBI chr18:20,285,758...87,080,053 JBrowse link
Q Mamtr7 Mammary tumor resistance QTL 7 IDA RGD PMID:19052818 RGD:2302423 NCBI chr10:9,841,807...108,540,162 JBrowse link
Q Mamtr8 Mammary tumor resistance QTL 8 IDA RGD PMID:19052818 RGD:2302423 NCBI chr18:32,670,352...87,080,053 JBrowse link
Q Mcs1 Mammary carcinoma susceptibility QTL 1 QTM RGD PMID:8168109 RGD:61080 NCBI chr 2:5,417,336...21,657,459 JBrowse link
Q Mcs15 Mammary carcinoma susceptibility QTL 15 IAGP RGD PMID:16568087 RGD:1581951 NCBI chr10:88,544,136...107,545,372 JBrowse link
Q Mcs16 Mammary carcinoma susceptibility QTL 16 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 1:1,868,045...43,724,576 JBrowse link
Q Mcs17 Mammary carcinoma susceptibility QTL 17 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 1:215,684,498...260,684,498 JBrowse link
Q Mcs18 Mammary carcinoma susceptibility QTL 18 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 2:5,417,336...42,777,046 JBrowse link
Q Mcs19 Mammary carcinoma susceptibility QTL 19 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 5:103,265,614...107,119,704 JBrowse link
Q Mcs2 Mammary carcinoma susceptibility QTL 2 QTM RGD PMID:9584103 RGD:61081 NCBI chr 7:24,738,680...40,433,335 JBrowse link
Q Mcs20 Mammary carcinoma susceptibility QTL 20 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 9:15,554,901...47,249,201 JBrowse link
Q Mcs21 Mammary carcinoma susceptibility QTL 21 IDA RGD PMID:16596452 RGD:1599317 NCBI chr10:30,021,354...54,057,745 JBrowse link
Q Mcs22 Mammary carcinoma susceptibility QTL 22 IDA RGD PMID:16596452 RGD:1599317 NCBI chr18:54,108,375...68,819,562 JBrowse link
Q Mcs23 Mammary carcinoma susceptibility QTL 23 IDA RGD PMID:17404222 RGD:1601189
Q Mcs24 Mammary carcinoma susceptibility QTL 24 IDA RGD PMID:17404222 RGD:1601189 NCBI chr 5:68,838,385...113,838,385 JBrowse link
Q Mcs26 Mammary carcinoma susceptibility QTL 26 IDA DMBA induced RGD PMID:20737482 RGD:4143380 NCBI chr 6:111,134,524...138,065,254 JBrowse link
Q Mcs27 Mammary carcinoma susceptibility QTL 27 IDA DMBA induced RGD PMID:20737482 RGD:4143380 NCBI chr13:48,776,655...53,264,877 JBrowse link
Q Mcs3 Mammary carcinoma susceptibility QTL 3 QTM RGD PMID:9584103 RGD:61081 NCBI chr 1:108,057,233...167,517,487 JBrowse link
Q Mcs4 Mammary carcinoma susceptibility QTL 4 QTM RGD PMID:9584103 RGD:61081 NCBI chr 8:20,717,592...65,717,592 JBrowse link
Q Mcs5 Mammary carcinoma susceptibility QTL 5 QTM RGD PMID:11139513 RGD:62417 NCBI chr 5:56,991,667...137,729,065 JBrowse link
Q Mcs6 Mammary carcinoma susceptibility QTL 6 QTM RGD PMID:11139513 RGD:62417 NCBI chr 7:33,044,449...71,352,127 JBrowse link
Q Mcs7 Mammary carcinoma susceptibility QTL 7 QTM RGD PMID:11139513 RGD:62417 NCBI chr10:75,544,754...112,626,471 JBrowse link
Q Mcs8 Mammary carcinoma susceptibility QTL 8 QTM RGD PMID:11139513 RGD:62417 NCBI chr14:4,833,233...26,466,248 JBrowse link
Q Mcsm1 Mammary carcinoma susceptibility modifier QTL 1 QTM RGD PMID:11139513 RGD:62417 NCBI chr 6:62,263,348...107,263,348 JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  mammalian phenotype 4999
    endocrine/exocrine gland phenotype 324
      abnormal gland morphology 272
        increased gland tumor incidence 83
          increased mammary gland tumor incidence 56
            increased fibroadenoma incidence 0
            increased mammary adenocarcinoma incidence + 47
            increased mammary gland ductal carcinoma incidence 0
            increased mammary gland fibroma incidence 0
            increased mammary gland tumor incidence in breeding females 0
            increased mammary gland tumor incidence in virgin females 0
Path 2
Term Annotations click to browse term
  mammalian phenotype 4999
    neoplasm 230
      altered tumor susceptibility 223
        abnormal tumor incidence 212
          increased tumor incidence 154
            increased organ/body region tumor incidence 132
              increased gland tumor incidence 83
                increased mammary gland tumor incidence 56
                  increased fibroadenoma incidence 0
                  increased mammary adenocarcinoma incidence + 47
                  increased mammary gland ductal carcinoma incidence 0
                  increased mammary gland fibroma incidence 0
                  increased mammary gland tumor incidence in breeding females 0
                  increased mammary gland tumor incidence in virgin females 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.